Integrating Radiomics Signature into Clinical Pathway for Patients with Progressive Pulmonary Fibrosis
Interstitial lung diseases (ILDs) are a heterogeneous group of pulmonary disorders characterised by variable degrees of inflammation, interstitial thickening, and fibrosis leading to distortion of the pulmonary architecture and gas exchange impairment. There are approximately 200 different entities...
Saved in:
| Main Authors: | Giacomo Sica, Vito D’Agnano, Simon Townend Bate, Federica Romano, Vittorio Viglione, Linda Franzese, Mariano Scaglione, Stefania Tamburrini, Alfonso Reginelli, Fabio Perrotta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/3/278 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of the COVID-19 pandemic on the profile of interstitial lung disease presenting to the pulmonary medicine department of a tertiary care center in western India
by: Unnati Desai, et al.
Published: (2025-03-01) -
Unveiling the radiological odyssey: Navigating the interstitial with artificial intelligence
by: Anna Russo, et al.
Published: (2024-11-01) -
Comparison of rituximab vs. cyclophosphamide in rheumatoid arthritis-associated interstitial lung disease and its correlation with spirometry
by: Mohammed Abdullah Saleem, et al.
Published: (2024-12-01) -
Methotrexate Use in Rheumatoid Arthritis-Related Interstitial Lung Disease (RA–ILD): Is It Beneficial?
by: Basma Mohamed Awad Mahmoud, et al.
Published: (2024-07-01) -
Idiopathic Pulmonary Fibrosis, Today and Tomorrow: Certainties and New Therapeutic Horizons
by: Giacomo Giulianelli, et al.
Published: (2025-05-01)